Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04198870 · ClinicalTrials.gov registry record · NA
MitraClip REPAIR MR Study
A NA study of Mitral Valve Regurgitation, sponsored by Abbott Medical Devices.
- Active
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 20
- Study locations
NCT04198870 is a NA study of Mitral Valve Regurgitation that is active but no longer recruiting, run by Abbott Medical Devices. The registered enrollment target is 500 participants, below the 769-participant average among 11 other Mitral Valve Regurgitation trials with a reported enrollment target (35% lower). The trial reports 20 study locations across 8 states.
The verdict
NCT04198870, a NA study of Mitral Valve Regurgitation, is active but no longer recruiting, sponsored by Abbott Medical Devices.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of this randomized controlled trial (RCT) is to compare the clinical outcome of MitraClip™ device versus surgical repair in patients with severe primary MR who are at moderate surgical risk and whose mitral valve has been determined to be suitable for correction by MV repair surgery by the cardiac surgeon on the local site heart team.
Conditions Studied
Interventions
- DEVICE MitraClip™ device implantation
- PROCEDURE Mitral Valve Repair Surgery
Study Locations (20)
California
- Scripps Health - La Jolla
- Sutter Medical Center, Sacramento - Sacramento
- University of California - Davis Medical Center - Sacramento
- Mercy General Hospital - Sacramento
- University of California at San Francisco - San Francisco
- Stanford University Medical Center - Stanford
- Los Robles Regional Medical Center - Thousand Oaks
Arizona
- Banner-University Medical Center Phoenix - Phoenix
- St. Josephs Hospital and Medical Center - Phoenix
- Arizona Cardiovascular Research Center - Phoenix
- Tucson Medical Center - Tucson
Alabama
- University Hospital - Univ. of Alabama at Birmingham (UAB) - Birmingham
- Cardiology Associates of Mobile, Inc. - Mobile
Florida
- Baptist Medical Center - Jacksonville
- NCH Healthcare System - Naples
Illinois
- Northwestern Memorial Hospital - Chicago
- Prairie Education & Research Cooperative - Springfield
Colorado
- Saint Joseph Hospital - Denver
Connecticut
- Yale New Haven Hospital - New Haven
Georgia
- Piedmont Heart Institute - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2020-07-21 |
| Est. Completion | 2035-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04198870
The ClinicalTrials.gov registry entry for NCT04198870 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 769-participant average among 11 other Mitral Valve Regurgitation trials with a reported enrollment target (35% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mitral Valve Regurgitation appearing as the primary indexed condition, and to 2 interventions - of which MitraClip™ device implantation is the first listed.
NCT04198870 reports 20 study locations spanning 8 distinct geographic areas - top geographies include California, Arizona, Alabama.
Frequently Asked Questions
What is clinical trial NCT04198870 about?
NCT04198870 is a clinical study titled "MitraClip REPAIR MR Study". The objective of this randomized controlled trial (RCT) is to compare the clinical outcome of MitraClip™ device versus surgical repair in patients with severe primary MR who are at moderate surgical risk and whose mitral valve has been determined to be suitable for correction by MV repair surgery by...
What is the current status of trial NCT04198870?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2020-07-21. Estimated completion is 2035-12.
What conditions does trial NCT04198870 study?
This clinical trial studies the following conditions: Mitral Valve Regurgitation.
What interventions are being tested in trial NCT04198870?
The interventions under investigation include: MitraClip™ device implantation (DEVICE), Mitral Valve Repair Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT04198870?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04198870 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mitral Valve Regurgitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)
RECRUITING · NA
-
AltaValve Pivotal Trial
RECRUITING · NA
-
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
RECRUITING · NA
-
Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System
ACTIVE NOT RECRUITING · NA
-
PARTNER 3 Trial - Mitral Valve in Valve
ACTIVE NOT RECRUITING · NA
-
Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional MR
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.